Sign in
4

Changes in Ownership

Inogen Inc Filed Acc 0000950170-24-053100

EVP, R&D & Chief Med. Officer gave up 16,695 shares (to pay taxes)

  • EVP, R&D & Chief Med. Officer acquired 32,638 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Glezer Stanislav EVP, R&D & Chief Med. Officer 2024-05-01 Option exercise +32,638 48,744 D
Glezer Stanislav EVP, R&D & Chief Med. Officer 2024-05-01 Shares withheld for taxes −16,695 $7.05 $117,700 32,049 D
Derivatives
Glezer Stanislav EVP, R&D & Chief Med. Officer 2024-05-01 Option exercise · Restricted Stock Unit −32,638 0 D
Loading xslF345X05/ownership.xml…